GILD logo

Gilead Sciences, Inc. (GILD) Shareholders equity

annual shareholders equity:

$19.33B-$3.50B(-15.34%)
December 31, 2024

Summary

  • As of today (August 22, 2025), GILD annual stockholders equity is $19.33 billion, with the most recent change of -$3.50 billion (-15.34%) on December 31, 2024.
  • During the last 3 years, GILD annual shareholders equity has fallen by -$1.74 billion (-8.25%).
  • GILD annual shareholders equity is now -15.34% below its all-time high of $22.83 billion, reached on December 31, 2023.

Performance

GILD Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDbalance sheet metrics

quarterly shareholders equity:

$19.67B+$512.00M(+2.67%)
June 30, 2025

Summary

  • As of today (August 22, 2025), GILD quarterly stockholders equity is $19.67 billion, with the most recent change of +$512.00 million (+2.67%) on June 30, 2025.
  • Over the past year, GILD quarterly shareholders equity has increased by +$1.39 billion (+7.62%).
  • GILD quarterly shareholders equity is now -20.81% below its all-time high of $24.84 billion, reached on September 30, 2017.

Performance

GILD quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

GILD Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-15.3%+7.6%
3 y3 years-8.3%-2.8%
5 y5 years-14.2%+9.1%

GILD Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-15.3%at low-13.8%+12.2%
5 y5-year-15.3%+6.2%-13.8%+12.8%
alltimeall time-15.3%>+9999.0%-20.8%>+9999.0%

GILD Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$19.67B(+2.7%)
Mar 2025
-
$19.16B(-0.9%)
Dec 2024
$19.33B(-15.3%)
$19.33B(+4.6%)
Sep 2024
-
$18.48B(+1.1%)
Jun 2024
-
$18.28B(+4.2%)
Mar 2024
-
$17.54B(-23.2%)
Dec 2023
$22.83B(+7.5%)
$22.83B(+2.3%)
Sep 2023
-
$22.31B(+5.5%)
Jun 2023
-
$21.16B(+0.8%)
Mar 2023
-
$21.00B(-1.1%)
Dec 2022
$21.24B(+0.8%)
$21.24B(+0.8%)
Sep 2022
-
$21.08B(+4.2%)
Jun 2022
-
$20.24B(+1.6%)
Mar 2022
-
$19.93B(-5.4%)
Dec 2021
$21.07B(+15.8%)
$21.07B(-1.9%)
Sep 2021
-
$21.47B(+9.0%)
Jun 2021
-
$19.70B(+4.0%)
Mar 2021
-
$18.95B(+4.1%)
Dec 2020
$18.20B(-19.2%)
$18.20B(+4.3%)
Sep 2020
-
$17.45B(-3.2%)
Jun 2020
-
$18.03B(-18.3%)
Mar 2020
-
$22.07B(-2.0%)
Dec 2019
$22.52B(+5.3%)
$22.52B(+9.3%)
Sep 2019
-
$20.60B(-8.9%)
Jun 2019
-
$22.62B(+3.0%)
Mar 2019
-
$21.95B(+2.6%)
Dec 2018
$21.39B(+4.6%)
$21.39B(-6.4%)
Sep 2018
-
$22.86B(+5.5%)
Jun 2018
-
$21.67B(+5.2%)
Mar 2018
-
$20.59B(+0.7%)
Dec 2017
$20.44B(+8.2%)
$20.44B(-17.7%)
Sep 2017
-
$24.84B(+9.6%)
Jun 2017
-
$22.68B(+10.9%)
Mar 2017
-
$20.44B(+8.2%)
Dec 2016
$18.89B(+1.9%)
$18.89B(+12.0%)
Sep 2016
-
$16.87B(+8.6%)
Jun 2016
-
$15.54B(+16.0%)
Mar 2016
-
$13.40B(-27.7%)
Dec 2015
$18.53B(+20.1%)
$18.53B(+6.4%)
Sep 2015
-
$17.41B(+6.9%)
Jun 2015
-
$16.29B(-5.2%)
Mar 2015
-
$17.18B(+11.4%)
Dec 2014
$15.43B(+35.7%)
$15.43B(+13.7%)
Sep 2014
-
$13.57B(-15.7%)
Jun 2014
-
$16.09B(+20.2%)
Mar 2014
-
$13.39B(+17.8%)
Dec 2013
$11.37B(+22.1%)
$11.37B(+4.5%)
Sep 2013
-
$10.88B(-1.9%)
Jun 2013
-
$11.09B(+9.3%)
Mar 2013
-
$10.15B(+9.0%)
Dec 2012
$9.31B(+38.2%)
$9.31B(+8.2%)
Sep 2012
-
$8.60B(+7.5%)
Jun 2012
-
$8.00B(+9.4%)
Mar 2012
-
$7.31B(+8.5%)
Dec 2011
$6.74B(+14.9%)
$6.74B(+10.2%)
Sep 2011
-
$6.12B(+1.2%)
Jun 2011
-
$6.05B(+1.7%)
Mar 2011
-
$5.95B(+1.4%)
Dec 2010
$5.86B(-7.9%)
$5.86B(+2.8%)
Sep 2010
-
$5.71B(-13.0%)
Jun 2010
-
$6.56B(-10.6%)
Mar 2010
-
$7.34B(+15.3%)
Dec 2009
$6.37B(+53.3%)
$6.37B(+12.8%)
Sep 2009
-
$5.65B(+8.8%)
Jun 2009
-
$5.19B(+8.0%)
Mar 2009
-
$4.80B(+15.7%)
Dec 2008
$4.15B
$4.15B(-0.3%)
DateAnnualQuarterly
Sep 2008
-
$4.17B(+10.4%)
Jun 2008
-
$3.77B(+13.3%)
Mar 2008
-
$3.33B(-3.8%)
Dec 2007
$3.46B(+90.6%)
$3.46B(+16.0%)
Sep 2007
-
$2.98B(+19.8%)
Jun 2007
-
$2.49B(+4.5%)
Mar 2007
-
$2.38B(+31.2%)
Dec 2006
$1.82B(-40.0%)
$1.82B(-45.0%)
Sep 2006
-
$3.30B(+3.2%)
Jun 2006
-
$3.20B(-5.6%)
Mar 2006
-
$3.39B(+11.9%)
Dec 2005
$3.03B(+61.8%)
$3.03B(+15.6%)
Sep 2005
-
$2.62B(+9.4%)
Jun 2005
-
$2.39B(+16.0%)
Mar 2005
-
$2.06B(+10.3%)
Dec 2004
$1.87B(+86.5%)
$1.87B(+34.1%)
Sep 2004
-
$1.40B(+10.1%)
Jun 2004
-
$1.27B(+11.9%)
Mar 2004
-
$1.13B(+12.9%)
Dec 2003
$1.00B(+75.5%)
$1.00B(+139.8%)
Sep 2003
-
$418.33M(+27.9%)
Jun 2003
-
$327.01M(+62.5%)
Mar 2003
-
$201.18M(-64.8%)
Dec 2002
$571.34M(+26.3%)
$571.34M(+9.3%)
Sep 2002
-
$522.83M(+9.8%)
Jun 2002
-
$476.04M(+4.2%)
Mar 2002
-
$456.94M(+1.0%)
Dec 2001
$452.44M(+28.9%)
$452.44M(+51.8%)
Sep 2001
-
$298.14M(-5.2%)
Jun 2001
-
$314.42M(-6.0%)
Mar 2001
-
$334.34M(-4.8%)
Dec 2000
$351.12M(+18.1%)
$351.12M(-6.6%)
Sep 2000
-
$376.10M(+24.5%)
Jun 2000
-
$302.21M(+0.4%)
Mar 2000
-
$301.04M(+1.3%)
Dec 1999
$297.29M(+9.9%)
$297.29M(-0.8%)
Sep 1999
-
$299.80M(+22.4%)
Jun 1999
-
$244.90M(-5.4%)
Mar 1999
-
$258.94M(+12.3%)
Dec 1998
$270.55M(-14.7%)
$230.55M(-19.0%)
Sep 1998
-
$284.66M(-5.3%)
Jun 1998
-
$300.45M(-3.5%)
Mar 1998
-
$311.42M(-1.9%)
Dec 1997
$317.35M(+8.8%)
$317.30M(-2.6%)
Sep 1997
-
$325.80M(-1.5%)
Jun 1997
-
$330.60M(+15.9%)
Mar 1997
-
$285.30M(-2.2%)
Dec 1996
$291.66M(+92.5%)
$291.70M(-2.1%)
Sep 1996
-
$297.90M(+3.7%)
Jun 1996
-
$287.30M(-3.5%)
Mar 1996
-
$297.70M(+85.1%)
Dec 1995
$151.50M(+31.4%)
-
Sep 1995
-
$160.80M(+102.3%)
Jun 1995
-
$79.50M(-7.7%)
Mar 1995
-
$86.10M(-8.9%)
Dec 1994
-
$94.50M(-7.4%)
Sep 1994
-
$102.00M(-6.2%)
Jun 1994
-
$108.70M(-5.7%)
Mar 1994
$115.28M(-17.3%)
$115.30M(-6.6%)
Dec 1993
-
$123.40M(-4.8%)
Sep 1993
-
$129.60M(-4.1%)
Jun 1993
-
$135.20M(-3.0%)
Mar 1993
$139.40M(+32.0%)
$139.40M(+0.5%)
Dec 1992
-
$138.70M(+36.5%)
Sep 1992
-
$101.60M(-2.3%)
Jun 1992
-
$104.00M(-1.5%)
Mar 1992
$105.59M(+935.2%)
$105.60M(+935.3%)
Mar 1991
$10.20M
$10.20M

FAQ

  • What is Gilead Sciences, Inc. annual stockholders equity?
  • What is the all time high annual shareholders equity for Gilead Sciences, Inc.?
  • What is Gilead Sciences, Inc. annual shareholders equity year-on-year change?
  • What is Gilead Sciences, Inc. quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Gilead Sciences, Inc.?
  • What is Gilead Sciences, Inc. quarterly shareholders equity year-on-year change?

What is Gilead Sciences, Inc. annual stockholders equity?

The current annual shareholders equity of GILD is $19.33B

What is the all time high annual shareholders equity for Gilead Sciences, Inc.?

Gilead Sciences, Inc. all-time high annual stockholders equity is $22.83B

What is Gilead Sciences, Inc. annual shareholders equity year-on-year change?

Over the past year, GILD annual stockholders equity has changed by -$3.50B (-15.34%)

What is Gilead Sciences, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of GILD is $19.67B

What is the all time high quarterly shareholders equity for Gilead Sciences, Inc.?

Gilead Sciences, Inc. all-time high quarterly stockholders equity is $24.84B

What is Gilead Sciences, Inc. quarterly shareholders equity year-on-year change?

Over the past year, GILD quarterly stockholders equity has changed by +$1.39B (+7.62%)
On this page